WHAT WE DO

HeartBeat.bio is a drug discovery company dedicated to developing a high-throughput human organoid screening platform for cardiac drug discovery. The technology platform is built on the worldwide first, self-organizing, highly scalable cardiac organoids (Cardioids) which uniquely recapitulate the physiology of human heart chambers and enable modeling of diseases such as drug-induced and genetic cardiomyopathies as well as myocardial infarction and fibrosis. The Cardioid-based screening platform will lead to more relevant drug candidates and thus significantly reduce time and cost of cardiac drug development.

our team

We are a bunch of scientists and industry experts with diverse backgrounds, different nationalities but a common goal!

Martina Cirigliano

Martina Cirigliano

Pablo Hofbauer

Pablo Hofbauer

Tamara Durovic

Tamara Durovic

Lokesh Pimpale

Lokesh Pimpale

Francesca Murganti

Francesca Murganti

Judith horvath

Rebecca Krasnik

Rebecca Kresnik

ruben van helden

Hannah Keresztes

Laurenz Krebs

Laurenz Krebs

Pia Hager

Emili Arasaverge

Emili Arasa Verge

funding partners

Cooperation partners